A service of StreetInsider.com
Ticker Symbol

Most Popular

AAPL 122.37
GOOG 632.59
MSFT 46.88
FB 95.21
BAC 18.13

Recently Added

CPRX 4.89
ACE 108.59
CRQE 0.00
HZNP 36.31
PMD 11.90

Gaining Speed

CPRX 4.89
PMD 11.90
ACE 108.59
CRQE 0.00
HZNP 36.31

ZIOPHARM Oncology (ZIOP) Reports Palifosfamide Hits PFS Events in Phase 3

ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP) announced today that the Phase 3 (PICASSO 3) trial of palifosfamide (ZIO-201) in first-line metastatic soft tissue sarcoma has reached its target number of progression-free survival (PFS) events. PICASSO 3 is an international, randomized, double-blind, placebo-controlled trial whose primary endpoint is PFS....

Read More




Get Alerted When News Hits On This Stock - FREE!